-Outlook Introduced to Nutrition Sensitive Integrated Farming System (NSIFS), or Poshan Kheti, by JEEViKA, Sushma Devi found that food produced in the family farm and kitchen garden was the perfect solution to feed her family sufficiently. Sushma Devi, a small farmer in Purnea, Bihar, was not able to provide diverse foods to her family of six members - comprising her husband, in-laws and children. Each of them has different dietary...
More »SEARCH RESULT
Total Matching Records found : 300
Many essential drugs priced much higher than manufacturing cost: WHO -Sushmi Dey
-The Times of India NEW DELHI: Around 40% of the essential medicines in India with lowest MRP are priced significantly higher than estimated production costs, an assessment by the World Health Organisation (WHO) shows highlighting the “exorbitant” profiteering by pharmaceutical companies and the scope for lowering prices of drugs. While innovative and newer drugs for cancer, hepatitis C and rare diseases are out of reach of many due to their unaffordable prices,...
More »MS Swaminathan, father of Green Revolution, interviewed by Jitheesh PM & Jipson John (Newsclick.in)
-Newsclick.in In an interview, the ‘father’ of India’s Green Revolution, says while technology is necessary, policies on procurement and public distribution are far more important in making agriculture economically viable and sustainable in the country. No one has played a more instrumental role in India’s self-sufficiency in food production than Dr MS Swaminathan — world-renowned agricultural scientist, known as the ‘Father of Green Revolution in India’. After getting a PhD from Cambridge...
More »Prices of essential medicines, stents to go up by over 4% -Rupali Mukherjee
-The Times of India MUMBAI: Prices of essential medicines, including painkillers, anti-infectives, supplements and antibiotics, will go up by over 4%, after the government gave its nod to the increase, in line with the annual Wholesale Price Index (WPI). Hike in prices of cardiac stents have also been allowed on the basis of WPI at 4.26% for calendar year 2018. The revision in prices of both stents and medicines will come...
More »Holes in cancer drug price cap -GS Mudur
-The Telegraph Call to govt to adopt 'cost-based' control The 30 per cent cap on profit margins imposed by India’s drug pricing authority on 42 anti-cancer drugs will have a limited impact on patients’ expenses because many of these medicines’ prices remain “prohibitive”, a network of patients’ rights groups said on Saturday. The All India Drug Action Network (Aidan) said the National Pharmaceutical Pricing Authority’s cap on profit margins in effect “legitimises” the...
More »
